DOI QR코드

DOI QR Code

Survival of Brain Metastatic Patients in Yazd, Iran

  • Akhavan, Ali (Department Of Radiotherapy, Isfahan University Of Medical Sciences) ;
  • Binesh, Fariba (Department Of Pathology, Shahid Sadoughi University Of Medical Sciences) ;
  • Heidari, Samaneh (Shahid Sadoughi University Of Medical Sciences)
  • Published : 2014.04.30

Abstract

Background: Brain metastasis occurs when cancerous cells come from a known (or sometimes an unknown) primary tumor to the brain and implant and grow there. This event is potentially lethal and causes neurologic symptoms and signs. These patients are treated in order to decrease their neurologic problems, increase quality of life and overall survival. Materials and Methods: In this study we evaluated clinical characteristics of 206 patients with brain metastases referred to our center from 2004 to 2011. Results: The mean age was 53.6 years. The primary tumors were breast cancer (32%), lung cancer (24.8%), lymphoma (4.4%), sarcoma (3.9%), melanoma (2.9%), colorectal cancer (2.4%) and renal cell carcinoma (1.5%). In 16.5% of the patients, brain metastasis was the first presenting symptom and the primary site was unknown. Forty two (20.4%) patients had a single brain metastasis, 18 patients (8.7%) had two or three lesions, 87 (42.2%) patients had more than three lesions. Leptomeningeal involvement was seen in 49 (23.8%) patients. Thirty five (17%) had undergone surgical resection. Whole brain radiation therapy was performed for all of the patients. Overall survival was 10.1 months (95%CI; 8.65-11.63). One and two year survival was 27% and 12% respectively. Conclusions: Overall survival of patients who were treated by combination of surgery and whole brain radiation therapy was significantly better than those who were treated with whole brain radiation therapy only [13.8 vs 9.3 months (p=0.03)]. Age, sex, primary site and the number of brain lesions did not show significant relationships with overall survival.

References

  1. Tehran, Iran: Cancer Office, Center for disease control, deputy for health, ministry of health and medical education; 2006. iranian annual of cancer Registration 2005-2006 (in Persian)
  2. Windsor AA, Koh ES, Allen S, et al (2013). Poor outcomes after whole brain radiotherapy in patients with brain metastases: results from an international multicentre cohort study. Clin Oncol (R CollRadiol), 25, 674-80 https://doi.org/10.1016/j.clon.2013.07.002
  3. Winn H. Richard, Youmans. Neurological Surgery, fifth ed. W.B.Saunder's, 2003: 1077.
  4. Wolf AL, Batra S, Bortoletto P, et al (2013). Stereotactic radiosurgery in treatment of cerebral metastases: histological differences in predictors of survival. Cureus, 5, 81.
  5. Yousefi KashiASH, Mofid B, Mirzaei HR, Azadeh P (2010). Overall survival and related prognostic factors in metastatic brain tumor treated with whole brain radiation therapy. J Res Med Sci, 4, 213-16.
  6. Nussbaum ES, Djalilian HR, Cho KH, Hall WA (1996). Brain metastases. histology, multiplicity, surgery, and survival. Cancer, 78, 1781-8. https://doi.org/10.1002/(SICI)1097-0142(19961015)78:8<1781::AID-CNCR19>3.0.CO;2-U
  7. Liu WJ, Zeng XT, Qin HF, et al (2012). Whole brain radiotherapy plus chemotherapy in the treatment of brain metastases from lung cancer: A meta-analysis of 19 randomized controlled trails. Asian Pac J Cancer Prev, 13, 3253-8. https://doi.org/10.7314/APJCP.2012.13.7.3253
  8. Miabi Z (2011). Metastatic brain tumors: A retrospective review in East Azarbyjan (Tabriz). Acta Med Iran, 49, 115-7.
  9. Nichols EM, Patchell RA, Regine WF, Kwok Y (2013). Palliation of brain and spinal cord metastases. In Perez And Brady's Principles And Practice Of Radiation Oncology, USA, 6th edition page 1766
  10. Saha A, Ghosh SK, Roy C, et al (2013). Demographic and clinical profile of patients with brain metastases: A retrospective study. Asian J Neurosurg, 8, 157-61 https://doi.org/10.4103/1793-5482.121688
  11. Saito EY, Viani GA, Ferrigno R, et al (2006). Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol, 1, 20 https://doi.org/10.1186/1748-717X-1-20
  12. Schackert G, Lindner C, Petschke S, Leimert M, Kirsch M (2013). Retrospective study of 127 surgically treated patients with multiple brain metastases: indication, prognostic factors, and outcome. Acta Neurochir, 155, 379-87 https://doi.org/10.1007/s00701-012-1606-8
  13. Soffietti R, Ruda R, Mutani R (2002). Management of brain metastases. J Neurol, 249, 1357-69. https://doi.org/10.1007/s00415-002-0870-6
  14. Song WG, Wang YF, Wang RL, et al (2013). Therapeutic regimens and prognostic factors of brain metastatic cancers. Asian Pac J Cancer Prev, 14, 923-7. https://doi.org/10.7314/APJCP.2013.14.2.923
  15. Stelzer KJ (2013). Epidemiology and prognosis of brain metastases. Surg Neurol Int, 4, 192-202
  16. Hazuka MB, Burleson WD, Stroud DN, et al (1993). Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy. J ClinOncol, 11, 369-73.
  17. Cai Y, Wang JY, Liu H (2013). Clinical Observation of whole brain radiotherapy concomitant with targeted therapy for brain metastasis in non-small cell lung cancer patients with chemotherapy failure. Asian Pac J Cancer Prev, 14, 5699-703. https://doi.org/10.7314/APJCP.2013.14.10.5699
  18. Duan L, Zeng R, Yang KH, et al (2014). Whole brain radiotherapy combined with stereotactic radiotherapy versus stereotactic radiotherapy alone for brain metastases: a meta-analysis. Asian Pac J Cancer Prev, 15, 911-5 https://doi.org/10.7314/APJCP.2014.15.2.911
  19. Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A (2000). Breast cancer in Iran: a review of 903 case records. Public Health. 114, 143-5.
  20. Hyun MK, Hwang JS, Kim JH (2013). Survival outcomes after whole brain radiation therapy and/or stereotactic radiosurgery for cancer patients with metastatic brain tumors in korea: a systematic review. Asian Pac J Cancer Prev, 14, 7401-7 https://doi.org/10.7314/APJCP.2013.14.12.7401
  21. Kebudi R, Ayan I, Gorgun O, et al (2005). Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol, 71, 43-8. https://doi.org/10.1007/s11060-004-4840-y
  22. Kim YZ, Kim KH, Kim JS, et al (2009). Clinical Analysis of Patients who Survived for Less than 3 Months After Brain Metastatectomy. J Korean Med Sci, 24, 641-8 https://doi.org/10.3346/jkms.2009.24.4.641
  23. Larson Da, Rubenstein Jl, Mcdermott Mw, Barani I (2011). Metastatic cancer to the brain. Devita, Hellman, and Rosenberg's Principles & Practice Of Oncology, USA, 9th edition page 2153.

Cited by

  1. Brain Metastases from Solid Tumors: an Institutional Study from South India vol.16, pp.13, 2015, https://doi.org/10.7314/APJCP.2015.16.13.5401
  2. Whole Brain Radiotherapy Combined with Stereotactic Radiosurgery versus Stereotactic Radiosurgery Alone for Brain Metastases vol.16, pp.17, 2015, https://doi.org/10.7314/APJCP.2015.16.17.7595
  3. Role of HER2 in Brain Metastasis of Breast Cancer: a Systematic Review and Meta-Analysis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1431
  4. Prognostic Factors in Patients with Non-small Cell Lung Carcinoma and Brain Metastases: a Malaysian Perspective vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1901
  5. A New Tool to Predict Survival after Radiosurgery Alone for Newly Diagnosed Cerebral Metastases vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2967